Vivimed Labs Ltd.

View in App
4.90 ▼0%

31 July 2023, 04:01:00 PM

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.vivimedlabs.com
Market Cap 40.63 Cr.
Enterprise Value(EV) 419.19 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) -39.62 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-03
Industry PE 37.95 Trailing Twelve Months Ending 2023-03
Book Value / Share 0.17 Trailing Twelve Months Ending 2023-03
Price to Book Value 28.55 Calculated using Price: 4.90
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 8.29 Cr. 82,913,915 Shares
FaceValue 2
About Vivimed Labs Ltd.
Vivimed Labs Ltd was originally incorporated as Emgi Pharmaceuticals & Chemicals Private Limited on 22-09-1988 with Registrar of Companies of Karnataka, Bangalore and subsequently converted into a public limited company on April 21, 1994. The name of the company has been changed to Vivimed Labs Limited on April 22,1997.

Vivimed Labs Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Vivimed Labs Ltd. Performance

View details >>
1 Day
1 Week
1 Month
3 Month
-10.91%
6 Month
-30.20%
1 Year
-52.66%
2 Year
-76.78%
5 Year
-90.96%
10 Year
-84.03%

Vivimed Labs Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 14.81 14.90 16.50 35.18 9.76 7.95 -20.75 -16.62 -18.80
Return on Capital Employed (%) 11.93 10.91 11.93 21.86 9.04 7.03 -2.69 -1.12 -3.54
Return on Assets (%) 3.90 3.86 4.25 10.44 3.43 2.44 -4.83 -4.13 -5.29

Vivimed Labs Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 560 559 585 734 1,226 944 835 432 364 39
Non Curr. Liab. 533 538 561 504 357 490 591 517 528 525
Curr. Liab. 744 801 897 817 790 889 770 341 373 424
Minority Int. 12
Equity & Liab. 1,837 1,898 2,044 2,055 2,386 2,322 2,196 1,289 1,266 988
Non Curr. Assets 846 906 911 961 1,104 1,092 1,221 761 759 656
Curr. Assets 971 992 1,133 1,094 1,282 1,231 975 529 507 332
Misc. Exp. not W/O 20 0 0
Total Assets 1,837 1,898 2,044 2,055 2,386 2,322 2,196 1,289 1,266 988

Vivimed Labs Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 1,351 1,380 1,346 1,462 1,186 1,315 1,059 861 237 172
Other Income 36 8 24 8 24 34 12 10 1 1
Total Income 1,387 1,388 1,369 1,470 1,209 1,349 1,071 871 239 173
Total Expenditure -1,166 -1,158 -1,123 -1,057 -985 -1,146 -1,052 -830 -245 -351
PBIDT 220 230 247 413 224 203 19 42 -7 -178
Interest -67 -86 -85 -68 -82 -70 -61 -56 -40 -37
Depreciation -66 -66 -61 -58 -56 -67 -67 -55 -18 -109
Taxation -20 -5 -16 -73 -10 -9 0 -2 -3 2
Exceptional Items
PAT 66 72 84 214 76 57 -109 -72 -68 -322
Minority Interest 2
Share Associate
Other Related Items
Consolidated Net Profit 66 72 84 214 78 57 -109 -72 -68 -322
Adjusted EPS 8 9 10 26 9 7 -13 -9 -8 -39

Vivimed Labs Ltd. Cash Flow

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 90 -118 140 154 58 21 422 80 567 28
Cash Fr. Inv. -170 -291 -107 -190 -68 -164 -89 -196 404 -16
Cash Fr. Finan. 67 419 -42 41 35 186 -338 72 -1,015 -10
Net Change -12 11 -8 4 25 44 -5 -44 -44 1
Cash & Cash Eqvt 24 35 27 31 55 99 95 50 6 7

Vivimed Labs Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 28.57 28.57 28.57 21.98 20.96 20.96 20.96 20.94 20.94
Public 71.43 71.43 71.43 78.02 79.04 79.04 79.04 79.06 79.06
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 54.20 54.20 54.20 40.02 37.11 37.11 37.11 37.06 37.06

Vivimed Labs Ltd. Announcements

View details >>
Mon, 11 Sep 2023
Extension Of Time For Holding Annual General Meeting Of The Company For The Financial Year Ended On March 31 2023
Extension of time for holding AGM
Mon, 14 Aug 2023
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of The Company
The Board of Directors of the Company at its meeting held on August 14 2023 inter alia have approved / resolved/ taken note of the following:1. Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 considered and approved the submission of the Un-audited Financial Results (Standalone & Consolidated) for the Quarter ended June 30 2023 attached herewith;2. Auditorss Limited Review Report on the Un-audited Financial Statements of the Company for the Quarter ended June 30 2023.3. To file an application to the office of the Registrar of Companies Bangalore Karnataka seeking an extension of time by three months for the convening of AGM for the Financial Year 2022-23The Board Meeting concluded at 20.30 P.M
Fri, 28 Jul 2023
Board Meeting Intimation for Notice Of Board Meeting / Closure Of Trading Window
VIVIMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 inter alia to consider and approve Notice of Board Meeting / Closure of Trading Window

Vivimed Labs Ltd. Technical Scans

View details >>

No Scans Found

Vivimed Labs Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 274,963.79 1,130.30 -1.4%
Divi's Laboratories Ltd. 99,404.71 3,722.50 -0.6%
Cipla Ltd. 97,455.33 1,184.50 -1.8%
Dr. Reddy's Laboratories Ltd. 94,594.48 5,557.40 -2.0%
Apollo Hospitals Enterprise Ltd. 72,171.99 4,994.00 -0.5%
Mankind Pharma Ltd. 69,708.40 1,739.10 0.0%
Torrent Pharmaceuticals Ltd. 63,451.75 1,840.55 -1.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 32.67 1,130.30 -1.4%
Divi's Laboratories Ltd. Consolidated 2023-06 67.23 3,722.50 -0.6%
Cipla Ltd. Consolidated 2023-06 31.32 1,184.50 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 20.07 5,557.40 -2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 108.04 4,994.00 -0.5%
Mankind Pharma Ltd. Consolidated 2023-03 54.38 1,739.10 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 50.36 1,840.55 -1.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.75 1,130.30 -1.4%
Divi's Laboratories Ltd. Consolidated 2023-06 7.57 3,722.50 -0.6%
Cipla Ltd. Consolidated 2023-06 4.00 1,184.50 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.86 5,557.40 -2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.52 4,994.00 -0.5%
Mankind Pharma Ltd. Consolidated 2023-03 5.69 1,739.10 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.65 1,840.55 -1.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,130.30 -1.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,722.50 -0.6%
Cipla Ltd. Consolidated 2023-03 0.02 1,184.50 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,557.40 -2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 4,994.00 -0.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,739.10 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,840.55 -1.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,130.30 -1.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,722.50 -0.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,184.50 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,557.40 -2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 4,994.00 -0.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,739.10 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,840.55 -1.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,130.30 -1.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,722.50 -0.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,184.50 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,557.40 -2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 4,994.00 -0.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,739.10 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,840.55 -1.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,130.30 -1.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,722.50 -0.6%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,184.50 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,557.40 -2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 4,994.00 -0.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,739.10 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,840.55 -1.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,130.30 -1.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,722.50 -0.6%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,184.50 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,557.40 -2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 4,994.00 -0.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,739.10 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,840.55 -1.8%

Vivimed Labs Ltd. FAQ's

What is Vivimed Labs share price?
Can I buy Vivimed Labs shares now?
What is the Market Cap of Vivimed Labs?
What are the key metrics to analyse Vivimed Labs?
What is the 52 Week High and Low of Vivimed Labs?